Discontinuation of anti-TNF-α treatment in IBD patients in remission prior to the 25th GW resulted neither in an increased risk of episodes during the rest of pregnancy nor in infusion reactions or loss of efficacy following postpartum reinitiation of IFX treatment [60]. Here, TNF is linked to inflammatory bowel disease.